Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study.
AUTOR(ES)
Hubble, J P
RESUMO
To test the hypothesis that Nocardia spp. may be an etiologic factor in Parkinson's disease (PD), we used a serodiagnostic panel to determine if PD patients had antibodies specific for Nocardia spp. To validate the serological test panel, sera from healthy volunteers and from patients with culture-proven nocardiosis (n = 307) were compared in part 1 of the study. The sensitivity of the panel was 88% for detection of culture-proven nocardial infections, and specificity was 85% (excluding cross-reactive leprosy cases). In part 2, no difference in seropositivity was found when PD patients were compared with their age- and gender-matched controls (n = 140). We found a high exposure rate of humans to nocardial antigens, especially among men and older individuals. Our results offer no support to the hypothesis that Nocardia spp. are causative in PD; however, it is possible that serological testing may not be optimal for detection of nocardial central nervous system infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=228573Documentos Relacionados
- Risk factors relevant to cystic breast disease: a case-control study.
- Autoimmune disease and risk for Parkinson disease: A population-based case-control study
- Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study
- Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.
- Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care